EconPapers    
Economics at your fingertips  
 

Merck blocks ‘safer’ gene therapy trials

Paul Smaglik

Nature, 2000, vol. 403, issue 6772, 817-817

Abstract: Washington Gene therapy researchers in Houston, Texas who recently reported success with a new ‘safer’ vector in animals may not get to test the vector in humans.

Date: 2000
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35002743 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:403:y:2000:i:6772:d:10.1038_35002743

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35002743

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:403:y:2000:i:6772:d:10.1038_35002743